Search by Drug Name or NDC
NDC 30698-0220-10 ANZEMET 50 mg/1 Details
ANZEMET 50 mg/1
ANZEMET is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Validus Pharmaceuticals LLC. The primary component is DOLASETRON MESYLATE.
MedlinePlus Drug Summary
Dolasetron is used to prevent nausea and vomiting caused by cancer chemotherapy. Dolasetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
Related Packages: 30698-0220-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dolasetron
Product Information
| NDC | 30698-0220 |
|---|---|
| Product ID | 30698-220_0df5b325-3209-4bbc-ab6b-a51aa6e52513 |
| Associated GPIs | 50250025200320 |
| GCN Sequence Number | 034749 |
| GCN Sequence Number Description | dolasetron mesylate TABLET 50 MG ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 33532 |
| HICL Sequence Number | 016576 |
| HICL Sequence Number Description | DOLASETRON MESYLATE |
| Brand/Generic | Brand |
| Proprietary Name | ANZEMET |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dolasetron mesylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/1 |
| Substance Name | DOLASETRON MESYLATE |
| Labeler Name | Validus Pharmaceuticals LLC |
| Pharmaceutical Class | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020623 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 30698-0220-10 (30698022010)
| NDC Package Code | 30698-220-10 |
|---|---|
| Billing NDC | 30698022010 |
| Package | 10 TABLET, FILM COATED in 1 BOTTLE (30698-220-10) |
| Marketing Start Date | 1997-09-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |